No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs563131640 |
chr2:47903052-47903053 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs530957363 |
chr2:47903093-47903094 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs74889028 |
chr2:47903156-47903157 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs188093450 |
chr2:47903168-47903169 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs182019576 |
chr2:47903198-47903199 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs528441297 |
chr2:47903232-47903233 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs368007046 |
chr2:47903236-47903237 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs568613362 |
chr2:47903237-47903238 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs536056445 |
chr2:47903373-47903374 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs143330935 |
chr2:47903382-47903383 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs76244477 |
chr2:47903395-47903396 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs563163553 |
chr2:47903431-47903432 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs146698652 |
chr2:47903435-47903436 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs140273275 |
chr2:47903456-47903457 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs576932708 |
chr2:47903463-47903464 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs534273547 |
chr2:47903476-47903477 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs371662008 |
chr2:47903485-47903486 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs75095531 |
chr2:47903488-47903489 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs150304333 |
chr2:47903496-47903497 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs137888767 |
chr2:47903509-47903510 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs149019576 |
chr2:47903512-47903513 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs76636608 |
chr2:47903541-47903542 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs545907924 |
chr2:47903565-47903566 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs527782107 |
chr2:47903570-47903571 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs11688709 |
chr2:47903595-47903596 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs566179908 |
chr2:47903609-47903610 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs374029941 |
chr2:47903638-47903639 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs546638431 |
chr2:47903640-47903641 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs533788164 |
chr2:47903662-47903663 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs562105173 |
chr2:47903745-47903746 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs372199028 |
chr2:47903749-47903750 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs143820788 |
chr2:47903760-47903761 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs553346759 |
chr2:47903875-47903876 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs138515601 |
chr2:47903906-47903907 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs187383423 |
chr2:47903952-47903953 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs376691273 |
chr2:47903985-47903986 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs369985668 |
chr2:47904000-47904001 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs77204584 |
chr2:47904023-47904024 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs570408788 |
chr2:47904044-47904045 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs534701880 |
chr2:47904048-47904049 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs552723359 |
chr2:47904073-47904074 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs574373137 |
chr2:47904077-47904078 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs535425156 |
chr2:47904078-47904079 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs200863942 |
chr2:47904092-47904093 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs7603494 |
chr2:47904096-47904097 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
46 |
rs144008817 |
chr2:47904134-47904135 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs575791388 |
chr2:47904137-47904138 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs376681295 |
chr2:47904144-47904145 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs545565951 |
chr2:47904204-47904205 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs373010688 |
chr2:47904219-47904220 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|